Am J Respir Crit Care Med
- KERCHBERGER VE, Bastarache JA
Pulmonary Vasculopathy in COVID-19 ARDS: A Step Closer to the Full Picture.
Am J Respir Crit Care Med. 2022 Jun 8. doi: 10.1164/rccm.202205-1019.
- VILLALBA JA, Hilburn CF, Garlin MA, Elliott GA, et al
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and ARDS.
Am J Respir Crit Care Med. 2022 Jun 7. doi: 10.1164/rccm.202109-2150.
Ann Intern Med
- KING D
Patients surviving COVID-19 had increased risk for adverse mental health outcomes
vs. persons without COVID-19.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0031.
- SHAH A, O'Horo JC
In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care
reduced all-cause mortality.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0033.
- VASSILOPOULOS A, Mylonakis E
In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir
reduced hospitalization or death.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0038.
- JOHNSON MG, Puenpatom A, Moncada PA, Burgess L, et al
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical
Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/M22-0729.
BMJ
- PANDEY BD, Morita K, Costello A
Twin crises in Nepal: covid-19 and climate change.
BMJ. 2022;377:o1434.
- PHIZACKERLEY D
Three more points about Paxlovid for covid-19.
BMJ. 2022;377:o1397.
- DYER O
Covid-19: Doctor who sold hydroxychloroquine as "magic bullet" treatment is
jailed.
BMJ. 2022;377:o1395.
- WISE J
Private cancer provider collapses despite drive to tackle NHS backlog.
BMJ. 2022;377:o1401.
Clin Chem
- AOKI A, Mori Y, Okamoto Y, Jinno H, et al
PCR-Based Screening Tests for SARS-CoV-2 Mutations: What Is the Best Way to
Identify Variants?
Clin Chem. 2022 Jun 7. pii: 6603702. doi: 10.1093.
Clin Infect Dis
- LIN Y, Yue S, Yang Y, Yang S, et al
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential
Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Variants of Concern (VOCs): A Small-scale Clinical Trial.
Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
- RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among
Health Care Workers with a Vaccine Mandate.
Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
- STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
- ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune
responses in recovered individuals.
Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
- DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
Maternal and perinatal outcomes associated with SARS-CoV-2 infection during
pregnancy, Florida, 2020-2021: A retrospective cohort study.
Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
- WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested
case control and self-controlled case series study.
Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
- BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination
Coverage-Connecticut, August-September 2021.
Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
- LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for
Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in
the United States.
Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
- LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron
variant in adults who received two doses of inactivated vaccine.
Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
Emerg Infect Dis
- SILA T, Sunghan J, Laochareonsuk W, Surasombatpattana S, et al
Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July-September 2021.
Emerg Infect Dis. 2022;28.
- DAOUK SK, Kamau E, Adachi K, Aldrovandi GM, et al
Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination,
California, USA.
Emerg Infect Dis. 2022;28.
Graefes Arch Clin Exp Ophthalmol
- MIRGHORBANI M, Bazvand F, Riazi-Esfahani H, Bahar MM, et al
Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic
with implementation of patients' masking.
Graefes Arch Clin Exp Ophthalmol. 2022 Jun 9. pii: 10.1007/s00417-022-05726.
Infect Control Hosp Epidemiol
- LI DF, Alhmidi H, Scott JG, Charnas IC, et al
A simulation study to evaluate contamination during reuse of N95 respirators and
effectiveness of interventions to reduce contamination.
Infect Control Hosp Epidemiol. 2022;43:764-769.
Int J Infect Dis
- BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in
a wide population of health care workers after BNT162b2 vaccination.
Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
- LAI X, Deng S, Hu L, Chen R, et al
J-shaped associations and joint effects of fasting glucose with inflammation and
cytokines on COVID-19 mortality.
Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
- HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
- KHONGYOT T, Moriyasu T
Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in
Japan between 2019 and 2022.
Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
Intensive Care Med
- LABRO G, Tubach F, Belin L, Dubost JL, et al
Nicotine patches in patients on mechanical ventilation for severe COVID-19: a
randomized, double-blind, placebo-controlled, multicentre trial.
Intensive Care Med. 2022 Jun 9. pii: 10.1007/s00134-022-06721.
- MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
Increased risk of central line-associated bloodstream infection in COVID-19
patients associated with dexamethasone but not with interleukin antagonists.
Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
J Infect
- LV P, Hu B, Hua R, Zhang J, et al
A novelly designed protein antagonist confers potent neutralization against
SARS-COV-2 variants of concern.
J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
- IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics
and linkage to severity of COVID-19 in hospital inpatients.
J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
- ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan
Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
- WANG B, Fu J, Lu A, Yang J, et al
Suitability assessment of CD24 targeted-therapy in the cancer patients with
COVID-19: Preliminary results from pan-cancer.
J Infect. 2022 May 31. pii: S0163-4453(22)00337.
- MELLON G, Rouquette A, Fac C, Carton B, et al
SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A
multicenter cross-sectional study.
J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
- LI Y, Guo Y, Duan Y
Changes in Streptococcus pneumoniae infection in children before and after the
COVID-19 pandemic in Zhengzhou, China.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
- STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
- GUO Z, Zhao S, Ryu S, Mok CKP, et al
Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1
variant in South Korea.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
- ZHANG Y, Li J, Jiang L, Chen Q, et al
Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2
subvariant infection.
J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
J Med Virol
- GIRAY BG, Acik GG
SARS-CoV-2and Mutation RT-qPCR Test Positivity Correlation with ABO and Rh Blood
Types.
J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27923.
- CHEN YQ, Ji YF, Chen JM
Dual impacts of the COVID-19 non-pharmaceutical interventions on other infectious
diseases.
J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27922.
- LI H, Chen Z, Liu X, Hu P, et al
T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1,
BA.2, BA.3 and GKA).
J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27925.
- CHEUNG CL, Ho SC, Krishnamoorthy S, Li GH, et al
COVID-19 and Platelet Traits: A Bi-directional Mendelian Randomization Study.
J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27920.
- MERCIER J, Osman M, Bouiller K, Tipirdamaz C, et al
Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients:
the ANOSVID study.
J Med Virol. 2022 Jun 7. doi: 10.1002/jmv.27918.
- IDIZ UO, Yurttas TT, Degirmencioglu S, Orhan B, et al
Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the
clinical course of Covid-19 patients.
J Med Virol. 2022 Jun 6. doi: 10.1002/jmv.27917.
- TSAGKARIS C, Eleftheriades A, Laubscher L, Vladyckuk V, et al
Viruses monkeying around with surgical safety: Monkeypox preparedness in surgical
settings.
J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27915.
- BREHM TT, Pfefferle S, von Possel R, Karolyi M, et al
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies
for SARS-CoV-2 delta and omicron variants.
J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27916.
- AU TY, Assavarittirong C
The potential rationale of COVID-19 vaccine-induced myopericarditis.
J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27910.
- SAIED AA, Nascimento MSL, Rangel AHDN, Skowron K, et al
Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent
biotherapeutics to counter important emerging viral pathogens with a special
focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus.
J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27907.
- ZHAO L, Li Y, Yi W, Yan K, et al
The clinical and bioinformatics analysis for the role of anti-hypertension drugs
on mortality among patients with hypertension hospitalized with COVID-19.
J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27914.
- MAK GCK, Lau SSY, Wong KKY, Lau CS, et al
Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2
Omicron variant BA.2 sublineage.
J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27908.
- NAH EH, Cho S, Park H, Kim S, et al
Antibody response after two doses of homologous or heterologous SARS-CoV-2
vaccines in healthcare workers at health promotion centers: a prospective
observational study.
J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27911.
- OKTAY GULTEKIN E, Gultekin O, Coskun A, Aksak T, et al
Antibody response three months after SARS-CoV-2 infection.
J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27909.
J Virol
- LAVIE M, Dubuisson J, Belouzard S
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry
Process in a Host Cell-Dependent Manner.
J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
- SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
A So-Far Overlooked Secondary Conformation State in the Binding Mode of
SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for
Estimating Infectivity Efficacy of the Underlying Virus Variant.
J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
- ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in
SARS-CoV-2 Infectivity".
J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
- CHEN X, Li J, Yang L, Zhou Y, et al
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification
and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
JAMA
- LARKIN HD
Warning Against Counterfeit At-home COVID-19 Tests.
JAMA. 2022;327:2067.
- RUBIN R
From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds
in Some Patients Who Take Paxlovid.
JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
- DOWELL D, Lindsley WG, Brooks JT
Reducing SARS-CoV-2 in Shared Indoor Air.
JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.
- LI Y
Characteristics and Outcomes of Hospitalized Patients in South Africa During the
COVID-19 Omicron Wave.
JAMA. 2022;327:2147-2148.
- LATRONICO N, Rasulo FA, Piva S
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2149.
- BAI W, Jackson T, Xiang YT
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2148-2149.
- SEVIN CM, Ely EW
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19.
JAMA. 2022;327:2149-2150.
- MASLO C, Toubkin M
Characteristics and Outcomes of Hospitalized Patients in South Africa During the
COVID-19 Omicron Wave-Reply.
JAMA. 2022;327:2148.
- HEESAKKERS H, van den Boogaard M, Zegers M
Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment
for COVID-19-Reply.
JAMA. 2022;327:2150-2151.
Lancet
- CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
Transforming or tinkering: the world remains unprepared for the next pandemic
threat.
Lancet. 2022;399:1995-1999.
Lancet Infect Dis
- USHER AD
FIND documents dramatic reduction in COVID-19 testing.
Lancet Infect Dis. 2022 Jun 2. pii: S1473-3099(22)00376.
- MONGE S, Rojas-Benedicto A, Olmedo C, Mazagatos C, et al
Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2
omicron (B.1.1.529) variant in Spain: a nationwide cohort study.
Lancet Infect Dis. 2022 Jun 2. pii: S1473-3099(22)00292.
MMWR Morb Mortal Wkly Rep
- KRISS JL, Hung MC, Srivastav A, Black CL, et al
COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization
Survey Adult COVID Module, United States, December 2020-November 2021.
MMWR Morb Mortal Wkly Rep. 2022;71:757-763.
- PAMPATI S, Rasberry CN, McConnell L, Timpe Z, et al
Ventilation Improvement Strategies Among K-12 Public Schools - The National
School COVID-19 Prevention Study, United States, February 14-March 27, 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:770-775.
N Engl J Med
- JOLOBE OMP
Protection Due to Previous SARS-CoV-2 Infection.
N Engl J Med. 2022;386.
- SCHERER EM, Babiker A, Adelman MW, Allman B, et al
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
- RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting the Immunocompromised from Covid-19.
N Engl J Med. 2022;386:e71.
- ABRAHAM J
Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
N Engl J Med. 2022;386:2236-2238.
Nature
-
Metal waste and dodging long COVID.
Nature. 2022;606:233.
-
Flying salamanders, falling lifespans - the week in infographics.
Nature. 2022 Jun 7. pii: 10.1038/d41586-022-01590.
Radiologia (Engl Ed)
- CALVILLO-BATLLES P, Cerda-Alberich L, Fonfria-Esparcia C, Carreres-Ortega A, et al
Development of severity and mortality prediction models for covid-19 patients at
emergency department including the chest x-ray.
Radiologia (Engl Ed). 2022;64:214-227.
Travel Med Infect Dis
- ALARCON-BRAGA EA, Hernandez-Bustamante EA, Salazar-Valdivia FE, Valdez-Cornejo VA, et al
Acceptance towards Covid-19 vaccination in Latin America and the Caribbean: A
systematic review and meta-analysis.
Travel Med Infect Dis. 2022 Jun 6:102369. doi: 10.1016/j.tmaid.2022.102369.
Zhonghua Jie He He Hu Xi Za Zhi
- LIU J, Wu JL, Liu GC, Jiang P, et al
[Research progress on physiological changes caused by wearing N95 mask in
patients with chronic obstruction pulmonary disease].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:598-602.
- XU FY, Zhai ZG
[Annual review of venous thromboembolism in 2021].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:588-592.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016